Catalyst Biosciences Inc
|Market Cap (Intraday)||128.28M|
|2yr Forward PE||N/A|
Catalyst Biosciences Inc Stock, NASDAQ:CBIO
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.